Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11746104 Chalcone-based chemotherapeutic compound for triple negative breast cancer

Patent 11746104 was granted and assigned to Qatar University on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Qatar University

Current Assignee

Qatar University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11746104

Patent Inventor Names

Ashraf Khalil

Ala-Eddin Al Moustafa

Feras Alali

Dana H. Elkhalifa

Date of Patent

September 5, 2023

Patent Application Number

16440861

Date Filed

June 13, 2019

Patent Citations

‌

US Patent 7714025 Modified chalcone compounds as antimitotic agents

‌

US Patent 7112698 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents

‌

US Patent 7563789 1-Adamantyl chalcones for the treatment of proliferative disorders

‌

US Patent 8236985 Compounds and uses thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11746104 Chalcone-based chemotherapeutic compound for triple negative breast cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API